| Stage | ROL | % of rev | ULS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $816M | 100.00% | ROL ×1.34 |
| Gross profit | $1.1B | 100.00% | $417M | 51.10% | ROL +48.9pp |
| Operating income | $223M | 20.45% | $150M | 18.38% | ROL +2.1pp |
| Pre-tax income | $213M | 19.51% | $338M | 41.42% | ULS +21.9pp |
| Net income | $158M | 14.49% | $254M | 31.13% | ULS +16.6pp |
| Stage | ROL | ULS | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $816M100.00% | ROL ×1.34 |
| Gross profit | 100.00%$1.1B | 51.10%$417M | ROL +48.9pp |
| Operating income | 20.45%$223M | 18.38%$150M | ROL +2.1pp |
| Pre-tax income | 19.51%$213M | 41.42%$338M | ULS +21.9pp |
| Net income |
| 14.49%$158M |
| 31.13%$254M |
| ULS +16.6pp |
None
No disclosed counterparties: ROL.